Cardiovascular & Hematological Disorders-Drug Targets

(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders)


Garry X. Shen
University of Manitoba
Winnipeg, MB


Become EABM
Become Reviewer

Helper T Cells Point the Way to Specific Immunotherapy for Autoimmune Disease

Volume:9   Issue: 3
Pp: 159-166
Andrew M. Hall, Mark A. Vickers, Robert N. Barker and Lars P. Erwig
DOI: 10.2174/187152909789007043

Role of PI3K/AKT, cPLA2 and ERK1/2 Signaling Pathways in Insulin Regulation of Vascular Smooth Muscle Cells Proliferation

Volume:9   Issue: 3
Pp: 172-180
Esma R. Isenovic, Mamdouh H. Kedees, Snezana Tepavcevic, Tijana Milosavljevic, Goran Koricanac, Andreja Trpkovic and Pierre Marche
DOI: 10.2174/187152909789007034

Contemporary Management of Hypertension - How to Optimize Therapy

Volume:9   Issue: 3
Pp: 181-192
Steve Leung and Debabrata Mukherjee
DOI: 10.2174/187152909789007061

Investigational Positive Inotropic Agents for Acute Heart Failure

Volume:9   Issue: 3
Pp: 193-205
Juan Tamargo, Ricardo Caballero, Ricardo Gomez, Adriana Barana, Irene Amoros and Eva Delpon
DOI: 10.2174/187152909789007070

Recent Advances in Biological Strategies for Targeted Drug Delivery

Volume:9   Issue: 3
Pp: 206-221
Xin Ye and Decheng Yang
DOI: 10.2174/187152909789007025